Clinical Trials
Neumora to lay off 35% of staff after navacaprant goes 0 for 3 in late-stage depression studies
FierceBiotech
2h ago
35% Move
Neumora's navacaprant has completed a clean sweep of trial misses in major depressive disorder.
Discussion
Sign in to join the discussion. Comments loading…